LB
Lexaria Bioscience Corp
🇺🇸XNAS.LEXXUnited StatesHealthcare
$1.03USDunchanged 0.00 (0%)OpenDelayed3:31 PM
Price$1.030.00 (0%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US52886N4060
- CUSIP
- 52886N406
Company
- Employees
- 7
- Headquarters
- Kelowna, United States
- CEO
- Mr. Richard C. Christopher
Market
- Shares outstanding
- 2.1M
- Market cap
- $25.63M
Highlights
- Market cap
- $25.63M
- EPS LTM
- -$4.74
- P/E LTM
- -0.22calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $194K-68.5%down year on year
- Net income
- -$7.73M+32.12%up year on year
- Gross margin
- 62.8%-31.37%down year on year
- Free cash flow
- -$7.53M+23.61%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.